Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ASO San Giovanni Battista di Torino, Turin
Steatotic grafts raise the risk for new-onset diabetes in liver transplant patients
November 4th, 2005
Steatotic grafts raise the risk for new-onset diabetes (NOD) in liver transplant patients. "The impact of NOD post-transplantation has been underestimated in the past. The aim of this study was to evaluate the incidence of diabetes after liver transplantation," researchers in Italy report. "We retrospectively analyzed the incidence of NOD in 899 patients transplanted in our center. According to International Consensus 2003 Guidelines, criteria for diagnosis of diabetes were: fasting plasma glucose {{>=}}126 mg/dL, symptoms of diabetes plus casual plasma glucose concentrations:200 mg/dL, and 2-hour plasma glucose levels {{>=}}200 mg/dL during an...
Source: Biotech Law Weekly (2005-11-04)
|
